How is Sarepta Therapeutics (SRPT) doing?

Sarepta Therapeutics is a company in the biotechnology industry, based in Cambridge, MA, worth $1.9B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.

Updated Oct 9, 2026

P3 score

Middling

Sarepta Therapeutics shares are down 24% over the past year, 34 points behind the S&P 500. Its type is Bottom Fished. Among large US stocks and funds it ranks in the 15th percentile on market beat, the 91st on staying power and the 34th on business growth. It appears on 1 of our dashboards.

$17.85−24% in a yearWorth $1.9B

Compare with ALNY · INSM · VRTX

Financials, earnings and news on Stox ›

Past year

The past year

Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.

SRPT against the S&P 500, past year

$100 a year ago. Sarepta Therapeutics −24%, the S&P 500 +16%.

SRPTS&P 500

What kind of stock is it?

Its type on Stox Atlas, from its four scores: beating or lagging the market, a steady or erratic rank, a growing or slowing business, and whether buyers or sellers lead.

Bottom Fished

LaggingSteadySlowingBought

Lagging steadily on a soft business, but buyers are stepping in.

NovDecJanFebMarAprMayJunJulAugSepNow

Bottom Fished this month; Rolling Over before that.

Also Bottom Fished (51 in all): PRGO · ULTA · AEP · MANH · BRK.B · META

EmbracedToppingAccumulatingRejectedStable rankBellwetherDistribution TopCoiled SpringWallflowerHolding rankFaith TradeRolling OverBottom FishedSleepy StapleUnsteady rankHot HandChurning WinnerTurning UpShow-Me GrowerBouncy rankSpeculative PopExhausted RallyFalling KnifeBroken Year

How is it doing against its group?

Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.

SRPT, past year−24%74 of 86 in the group

Rest of the group+21%equal-weighted

S&P 500+16%past year

Sarepta Therapeutics is −24% over the past year, against +21% for the rest of the group and +16% for the S&P 500. It ranks 74th of 86 in Health care.

SRPTRest of the group

Best in the groupRVMD Revolution Medicines+297%ILMN Illumina+184%NTRA Natera+133%

Worst in the groupPODD Insulet−57%BSX Boston Scientific−56%RARE Ultragenyx−50%

Health care on Stox ›

How much does it move?

Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.

About usual Sarepta Therapeutics typically moves 5.6% in a day, about usual for it, and it swings more than 96% of large US stocks.

Typical day5.6%about $0.99 a share

Its usual6.2%about usual, 0.9× its year’s average

Against the S&P 5005.6×the index’s typical day is 1.1%

Unusual day±11.1%twice its typical day

Deepest fall, past year−39%now 27% below its high

In the S&P’s down weeks243%of the index’s fall, three years; beta 1.0

Typical daily move (ATR)Its year’s average 6.18%

SRPT on our dashboards

Every question where Sarepta Therapeutics appears, in the order of the home page, with its reading and place in that table. Select a question to open it with SRPT highlighted. Select a column to sort.

Question	Reading	Place	Details
Which stocks are most shorted? Who’s buying and selling	98Heavily shorted	21 of 60	% of float 24.1% · Days to cover 8.6 · Since last report −2.8 pts

Go deeper on Stox

SRPT’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.

Open SRPT on Stox ›All 16 types on Atlas ›Its group on Stox ›

How to read this page

How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.

Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.

Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.

Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.

For financial statements, earnings and news, see SRPT’s full profile on Stox.

This page is information, not investment advice. About our data and methods ›

Full profile on Stox ›Health care stocks ›